ClinConnect ClinConnect Logo
Search / Trial NCT01962506

Diagnostic Utility of Copeptin in Addition to High-sensitivity Cardiac Troponin for the Early Diagnosis of NSTE-ACS

Launched by G. D'ANNUNZIO UNIVERSITY · Oct 10, 2013

Trial Information

Current as of June 15, 2025

Unknown status

Keywords

Chest Pain Copeptin High Sensitivity Cardiac Troponin Non St Elevation (Nste) Acs

ClinConnect Summary

The evaluation of chest pain patients in the emergency department remains a costly and difficult challenge, because a large proportion of them do not suffer from an acute coronary syndrome (ACS). The adequate ruling out of ACS in patients with chest pain is crucial, as the erroneous discharge of a patient with ACS is associated with a high risk of cardiac events. Rapid assessment of these patients is critical to direct further diagnostic and therapeutic strategies. Electrocardiography (ECG) and cardiac troponin (cTn) are the current diagnostic cornerstones and complement clinical assessment...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Chest pain duration \> 5 minutes at rest or upon minimal exertion
  • Chest pain onset \< 6 hours
  • Non-traumatic chest pain
  • Exclusion Criteria:
  • Cardiac arrest
  • STEMI
  • New left bundle branch block

About G. D'annunzio University

G. D'Annunzio University, located in Chieti-Pescara, Italy, is a prominent academic institution committed to advancing scientific research and innovation in the health sciences. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that encourages the development of novel therapeutic strategies and clinical applications. As a clinical trial sponsor, G. D'Annunzio University seeks to contribute to the improvement of patient outcomes through rigorous research methodologies, ethical standards, and a focus on translational medicine. Their dedication to education and research excellence positions them as a key player in the advancement of healthcare solutions.

Locations

Chieti, , Italy

Patients applied

0 patients applied

Trial Officials

Fabrizio Ricci

Principal Investigator

Institute of Cardiology and Center of Excellence on Aging, "G. D'Annunzio" University, Chieti, Italy

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials